Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Non-Muscle Invasive Bladder Neoplasms Clinical Trials

3 recruiting trials for Non-Muscle Invasive Bladder Neoplasms. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
1
Phase 3 Trials
2
Sponsors

Recruiting Trials

RECRUITINGNCT07309445

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer...

The purpose of this study is to assess how well TAR-200 works in real-word by measuring the time taken from the first TAR-200 insertion to worsening of cancer or until the signs...

Sponsor: Janssen Research & Development, LLCEnrolling: 1501 location
RECRUITINGPhase 2NCT06833073

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Researchers are looking for new ways to treat people with high-risk non-muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of the...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 30820 locations
RECRUITINGPhase 3NCT06319820

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's choice of intravesical...

Sponsor: Janssen Research & Development, LLCEnrolling: 64120 locations